echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Site-Directed Mutagenesis and Gene Fusion by Megaprimer PCR

    Site-Directed Mutagenesis and Gene Fusion by Megaprimer PCR

    • Last Update: 2020-11-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the last few years, a variety of polymerase chain reaction (
    PCR
    )-based mutagenesis procedures have been developed (
    1

    16
    ). Among these, the three-primer two-PCR methods (
    1

    3
    ) represented by the original “megaprimer” technique (
    1
    ), appear to be the simplest and most versatile ones available. A number of recent improvements and modifications of the megaprimer method have contributed to an increase in its yield, creation of a larger variety of mutations, and reduction of unwanted mutational errors (
    17

    23
    ). The rationale of the basic method is shown schematically in Fig. 1
    A
    , where A and B represent the “flanking” primers that can map either within the cloned gene or outside the gene (i.e., within the vector sequence) and M represents the internal “mutant” primer containing the desired base change. The first PCR is performed using the mutant primer (e.g., M1 in Fig. 1 ) and one of the flanking primers (e.g., A). The double-stranded product is purified and used as one of the primers (hence the name “megaprimer”) in the second PCR along with the other flanking primer (B). The wild-type cloned gene is used as a template in both PCR reactions. The final PCR product containing the mutation can be used in a variety of standard applications, such as cloning in expression vectors and sequencing, or in more specialized applications, such as production of the gene message in vitro if primer A (or the template sequence downstream of primer A) also contains a transcriptional promoter (e.g., that of SP6 or T7 phage). Both primers A and B are usually designed to contain convenient restriction sites so that the final, mutant PCR product can be restricted and cloned. This basic procedure can be adopted to create site-specific insertions (Fig. 1
    B
    ), deletions (Fig. 1
    C
    ), or gene fusions (Fig. 1
    D
    ) by designing appropriate “mutant” primers (M) for the first PCR.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.